Health Canada has reaffirmed its commitment to safeguarding the country’s drug supply, stating it is “taking all necessary action” to ensure Canadians have continued access to essential prescription medications. This…
Dr. Mark Stetter Joins Zoetis Board of DirectorsDean of the University of California, Davis School of Veterinary Medicine brings extensive and valuable experience in animal health to Zoetis Board (NYSE:…
Eli Lilly to Present New Data on Imlunestrant, Olomorasib, LY4170156, and Verzenio® at 2025 ASCO Annual Meeting Eli Lilly and Company (NYSE: LLY) announced today that new clinical data from…
New data from SEQUOIA, to be reported in two oral presentations, underscore the benefits of BRUKINSA® as first-line treatment for patients with chronic lymphocytic leukemia (CLL) Promising early phase data show…
The U.S. Bankruptcy Court of New Jersey approved CVS Pharmacy® bids on the prescription files of 625 Rite Aid pharmacies across 15 states in areas that CVS serves, as well 64…
Johnson & Johnson MedTech Launches SOUNDSTAR CRYSTAL™ Ultrasound Catheter in the U.S. to Enhance Cardiac Ablation Procedures May 2025 – Johnson & Johnson MedTech, a global leader in cardiac arrhythmia…
Access to Obesity Medications Shouldn’t Be This Hard Recent changes in insurance coverage have forced thousands of Americans living with obesity into an impossible choice: stop taking a safe, effective…
Eli Lilly’s Kisunla Receives Regulatory Approval in Australia for Early Alzheimer’s Treatment Eli Lilly and Company (NYSE: LLY) announced today that Australia’s Therapeutic Goods Administration (TGA) has granted marketing authorization…
Aetna Better Health® of Illinois Invests $20.4 Million in Value-Based Care to Improve Health Outcomes in Underserved Communities Aetna Better Health® of Illinois, a CVS Health® company (NYSE: CVS), has…
AstraZeneca Showcases Oncology Breakthroughs at ASCO 2025, Reinforcing Mission to Eliminate Cancer as a Cause of Death AstraZeneca will present new data from over 80 abstracts at the 2025 American…
Roche Presents Positive ODAC Discussion on Columvi® Combination Therapy for Aggressive Lymphoma Basel, Switzerland – May 21, 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food…
FDA Under Makary Eyes New Pathway for Rare Disease Drugs Amid Debate Over Feasibility and Safety While the U.S. Food and Drug Administration (FDA) under new Health and Human Services…